Synthesis and Molecular Modeling Studies on Novel C2 Alkylated Benzoazonine Scaffold and Corresponding 2-Pyrazoline Derivatives as Acetylcholinestrase Enzyme Inhibitors

References

• N. Kaur, “Metal Catalysts: Applications in Higher-Membered N-Heterocycles Synthesis,” Journal of the Iranian Chemical Society 12, no. 1 (2015): 9.
   Web of Science ®Google Scholar
• G. Lahm, A. Stoye, and T. Opatz, “A Five-Step Synthesis of (±)-Tylophorine via a Nitrile-Stabilized Ammonium Ylide,” The Journal of Organic Chemistry 77, no. 15 (2012): 6620.
   PubMed Web of Science ®Google Scholar
• B. M. Smith, J. M. Smith, J. H. Tsai, J. A. Schultz, C. A. Gilson, S. A. Estrada, R. R. Chen, D. M. Park, E. B. Prieto, C. S. Gallardo, et al. “Discovery and SAR of New Benzazepines as Potent and Selective 5-HT(2C) Receptor Agonists for the Treatment of Obesity,” Bioorganic & Medicinal Chemistry Letters 15, no. 5 (2005): 1467.
   PubMed Web of Science ®Google Scholar
• D. Boeglin, D. Bonnet, and M. Hibert, “Solid-Phase Preparation of a Pilot Library Derived from the 2,3,4,5-Tetrahydro-1H-Benzo[b]Azepin-5-Amine Scaffold,” Journal of Combinatorial Chemistry 9, no. 3 (2007): 487.
   PubMedGoogle Scholar
• C. Roxburgh, “The Synthesis and Stereochemistry of Some New Medium-Ring Nitrogen-Containing Alcohols and Related Compounds,” Tetrahedron 50, no. 46 (1994): 13199.
   Web of Science ®Google Scholar
• G. Maas, R. Reinhard, and H.-G. Herz, “Two-Carbon Ring Enlargement of Five-, Six-, and Seven-Membered 1-Aza-2-Vinylcycloalk-2-Enes with Dimethyl Acetylenedicarboxylate and Subsequent Thermal Isomerization Reactions,” Zeitschrift Für Naturforschung B 61b (2006): 385.
   Google Scholar
• E. M. Afsah, A. A. Fadda, S. Bondock, and M. M. Hammouda, “Synthesis and Some Reactions of Functionalized Benzo[b]Azonines and Bi(Benzo[b]Azonines),” Z. Naturforsch 64b (2009): 415.
   Google Scholar
• E. M. Afsah, A. A. Fadda, S. Bondock, and M. M. Hammouda, “Synthesis and Some Reactions of Functionalized 11,12-Dihydro-5H-Dibenzo[b,g] Azonines,” Zeitschrift Für Naturforschung B 70, no. 6 (2015): 385.
   Google Scholar
• K. Peter, C. Vollhardt, and M. J. Eichberg, Strategies and Tactics in Organic Synthesis (Academic Press, 2004), 4, 407.
   Google Scholar
• D. L. Klayman, J. P. Scovill, J. F. Bartosevich, and C. J. Mason, “2-Acetylpyridine Thiosemicarbazones. 2. N4,N4-Disubstituted Derivatives as Potential Antimalarial Agents,” Journal of Medicinal Chemistry 22, no. 11 (1979): 1367.
   PubMed Web of Science ®Google Scholar
• E. D. Thorsett, E. E. Harris, S. D. Aster, E. R. Peterson, J. P. Snyder, J. P. Springer, J. Hirshfield, E. W. Tristram, A. A. Patchett, E. U. Ulm, et al., “Conformationally Restricted Inhibitors of Angiotensin-Converting Enzyme. Synthesis and Computations,” Journal of Medicinal Chemistry 29, no. 2 (1986): 251.
   PubMed Web of Science ®Google Scholar
• C. R. Clark, P. R. Halfpenny, R. G. Hill, D. C. Horwell, J. Hughes, T. C. Jarvis, D. C. Rees, and D. Schofield, “Highly Selective.Kappa. Opioid Analgesics. Synthesis and Structure-Activity Relationships of Novel N-[(2-Aminocyclohexyl)Aryl]Acetamide and N-[(2-Aminocyclohexyl)Aryloxy]Acetamide Derivatives,” Journal of Medicinal Chemistry 31, no. 4 (1988): 831.
   PubMed Web of Science ®Google Scholar
• A. Lévai, “Synthesis of Exocyclic α,β-Unsaturated Ketones,” Arkivoc 7 (2004): 15.
   Google Scholar
• A. Lévai, “Synthesis of Heterocyclic Compounds by the Reactions of Exocyclic α,β‐Unsaturated Ketones,” Journal of Heterocyclic Chemistry 41, no. 3 (2004): 299.
   Web of Science ®Google Scholar
• A. Lévai, K. E. Kövér, and J. Jekõ, “Fused Heterocycles 11. Synthesis of Tricyclic Fused Pyrazolines by the Reaction of 3-Arylidenechromanones and 3-Arylidene-1-Thiochromanones with Hydrazine,” Arkivoc 8 (2007): 26.
   Google Scholar
• A. Lévai and J. Jekõ, “Oxazepines and Thiazepines 46. Synthesis of Tetracyclic 1, 5 Benzothiazepines by the Reaction of α, β, γ, δ-Unsaturated Ketones with 2-Aminothiophenol,” Arkivoc 17 (2008): 234.
   Google Scholar
• J. B. Harborne (Ed.), Flavonoids: Advances in Research Since 1983 (London, UK: Chapman & Hall, 1994), 15.
   Google Scholar
• R. Mondal, T. K. Mandal, and A. K. Mallik, “An Expeditious and Safe Synthesis of Some Exocyclic α,β-Unsaturated Ketones by Microwave-Assisted Condensation of Cyclic Ketones with Aromatic Aldehydes over Anhydrous Potassium Carbonate,” Organic Chemistry International 18 (2012): 1.
   Google Scholar
• T. Shankar, R. Gandhidasan, S. Venkataraman, “Synthesis and Characterization and Anti-Inflammatory and Antibacterial Evaluation of 3-arylidene-7-methoxychroman-4-ones,” Indian Journal of Chemistry B 50 (2011): 1202.
   Google Scholar
• B. Uttara, A. V. Singh, P. Zamboni, and R. T. Mahajan, “Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic Options,” Current Neuropharmacology 7, no. 1 (2009): 65.
   PubMed Web of Science ®Google Scholar
• X. Chen, C. Guo, and J. Kong, “Oxidative Stress in Neurodegenerative Diseases,” Journal of Neural Regeneration Research 7no. 5 (2012): 376.
   PubMed Web of Science ®Google Scholar
• R. Sultana, M. Perluigi, and D. A. Butterfield, “Oxidatively Modified Proteins in Alzheimer's Disease (AD), Mild Cognitive Impairment and Animal Models of AD: Role of Abeta in Pathogenesis,” Acta Neuropathologica 118, no. 1 (2009): 131.
   PubMed Web of Science ®Google Scholar
• X. Zhu, B. Su, X. Wang, M. A. Smith, and G. Perry, “Causes of Oxidative Stress in Alzheimer disease,” Cellular and Molecular Life Sciences 64, no. 17 (2007): 2202
   PubMed Web of Science ®Google Scholar
• Seema Bag, Sanjukta Ghosh, Rekha Tulsan, Abha Sood, Weihong Zhou, Christine Schifone, Michelle Foster, Harry LeVine, Béla Török, and Marianna Török, “Design, Synthesis and Biological Activity of Multifunctional α,β-Unsaturated Carbonyl Scaffolds for Alzheimer’s Disease,” Bioorganic & Medicinal Chemistry Letters 23, no. 9 (2013): 2614.
   PubMed Web of Science ®Google Scholar
• D. Silva, M. Chioua, A. Samadi, P. Agostinho, P. Garçao, R. Lajarín-Cuesta, C. de los Ríos, I. Iriepa, I. Moraleda, L. Gonzalez-Lafuente, et al. “Synthesis, Pharmacological Assessment, and Molecular Modeling of Acetylcholinesterase/Butyrylcholinesterase Inhibitors: Effect against Amyloid-β-Induced Neurotoxicity,” ACS Chemical Neuroscience 4, no. 4 (2013): 547.
   PubMed Web of Science ®Google Scholar
• Thomas Philip Robinson, Tedman Ehlers, Richard B. Hubbard IV, Xianhe Bai, Jack L. Arbiser, David J. Goldsmith, and JPhillip Bowen, “Design, Synthesis, and Biological Evaluation of Angiogenesis Inhibitors: aromatic Enone and Dienone Analogues of Curcumin,” Bioorganic & Medicinal Chemistry Letters 13, no. 1 (2003): 115.
   PubMed Web of Science ®Google Scholar
• T. P. Robinson, R. B. Hubbard, T. J. Ehlers, J. L. Arbiser, D. J. Goldsmith, and J. P. J. Bowen, “Synthesis and Biological Evaluation of Aromatic Enones Related to Curcumin,” Bioorganic & Medicinal Chemistry 13, no. 12 (2005): 4007.
   PubMed Web of Science ®Google Scholar
• A. P. T. Augustine, E. A. Varadharajan, and M. V. B. Scholastica, “Green Synthesis of Dispiroheterocycles through a Microwave Induced Solvent Free Approach and a Study on Its Biological Activity,” Der Pharma Chemica 8, no. 19 (2016): 311.
   Google Scholar
• Donghang Cheng, Sergio Valente, Sabrina Castellano, Gianluca Sbardella, Roberto Di Santo, Roberta Costi, Mark T. Bedford, and Antonello Mai, “Novel 3,5-Bis(Bromohydroxybenzylidene)Piperidin-4-Ones as Coactivator-Associated Arginine Methyltransferase 1 Inhibitors: Enzyme Selectivity and Cellular Activity,” Journal of Medicinal Chemistry 54, no. 13 (2011): 4928.
   PubMed Web of Science ®Google Scholar
• S. Kumar, S. Bawa, S. Drabu, R. Kumar, and H. Gupta, “Biological Activities of Pyrazoline Derivatives – A Recent Development,” Recent Patents on anti-Infective Drug Discovery 4, (2009): 154.
   PubMedGoogle Scholar
• M. A. Rahman and A. A. Siddiqui, “Pyrazoline Derivatives: A Worthy Insight into the Recent Advances and Potential Pharmacological Activities,” International Journal of Pharmaceutcal Science and Drug Research 2 (2010): 165.
   Google Scholar
• M. R. Shaaban, A. S. Mayhoub, and A. M. Farag, “Recent Advances in the Therapeutic Applications of Pyrazolines,” Expert Opinion on Therapeutic Patents 22, no. 3 (2012): 253.
   PubMed Web of Science ®Google Scholar
• G. Holan, C. T. Virgona, K. G. Watson, and B. L. Finkelstein, “Synthesis, Insecticidal and anti-Acetylcholinesterase Activity of a New Class of Heterocyclic Methanesulfonates,” Bioorganic & Medicinal Chemistry Letters 6, no. 1 (1996): 77.
   Web of Science ®Google Scholar
• V. Jayaprakash, S. Yabanoglu, B. N. Sinha, and G. Ucar, “Pyrazoline-Based Mycobactin Analogues as Dual Inhibitors of MAO/Cholinesterase,” Turkish Journal of Biochemistry 35, no. 2 (2010): 91.
   Google Scholar
• G. Ucar, N. Gokhan, A. Yesilada, and A. A. Bilgin, “1-N-Substituted Thiocarbamoyl-3-Phenyl-5-Thienyl-2-Pyrazolines: A Novel Cholinesterase and Selective Monoamine Oxidase B Inhibitors for the Treatment of Parkinson's and Alzheimer's Diseases,” Neuroscience Letters 382, no. 3 (2005): 327.
   PubMed Web of Science ®Google Scholar
• L. J. Dolby, and D. L. Booth, “The Periodate Oxidation of Indoles,” Journal of the American Chemical Society 88, no. 5 (1966): 1049.
   Web of Science ®Google Scholar
• E. V. Dehmlow and R. Kramer, “Preparation and Pyrolysis of Stereoisomeric Bromobicyclo[n.l.0]Alkanes (n = 6, 8, 10),” Zeitschrift Für Naturforschung B 42b (1987): 489.
   Google Scholar
• M. Perscheid, D. Schollmeyer, and U. Nubbemeyer, “First Synthesis of Medium-Sized Ring Allenyl Lactams,” European Journal of Organic Chemistry 2011, no. 27 (2011): 5250.
   Web of Science ®Google Scholar
• P. A. Thompson, D. E. Wright, C. E. Counsell, and J. Zajicek, “Statistical Analysis, Trial Design and Duration in Alzheimer's Disease Clinical Trials: A Review,” International Psychogeriatrics 24, no. 5 (2012): 689.
   PubMed Web of Science ®Google Scholar
• C. Hyde, J. Peters, M. Bond, G. Rogers, M. Hoyle, R. Anderson, M. Jeffreys, S. Davis, P. Thokala, and T. Moxham, “Evolution of the Evidence on the Effectiveness and Cost-Effectiveness of Acetylcholinesterase Inhibitors and Memantine for Alzheimer's Disease: Systematic Review and Economic Model,” Age and Ageing 42, no. 1 (2013): 14.
   PubMed Web of Science ®Google Scholar
• R. Howard, R. McShane, J. Lindesay, C. Ritchie, A. Baldwin, R. Barber, A. Burns, T. Dening, D. Findlay, C. Holmes, et al. “Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease,” New England Journal of Medicine 366, (2012): 893.
   PubMed Web of Science ®Google Scholar
• E. Perry, M. Walker, J. Grace, and R. Perry, “Acetylcholine in Mind: A Neurotransmitter Correlate of Consciousness?” Trends in Neurosciences 22 (1999): 273.
   PubMed Web of Science ®Google Scholar
• Voet, D.; Voet, J. G. Biochemistry. New York: John Wiley and Sons (1995).
   Google Scholar
• R. M. Lane, S. G. Potkin, and A. Enz, “Targeting Acetylcholinesterase and Butyrylcholinesterase in Dementia,” The International Journal of Neuropsychopharmacology 9, no. 01 (2005): 101.
   PubMedGoogle Scholar
• E. Giacobini, “Cholinesterase Inhibitors: New Roles and Therapeutic Alternatives,” Pharmacological Research 50, no. 4 (2004): 433.
   PubMed Web of Science ®Google Scholar